See more : Nissin Foods Holdings Co.,Ltd. (NFPDF) Income Statement Analysis – Financial Results
Complete financial analysis of Clínica Baviera, S.A. (CBAV.MC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clínica Baviera, S.A., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Tower Semiconductor Ltd. (TSEM.TA) Income Statement Analysis – Financial Results
- Elitegroup Computer Systems Co.,Ltd. (2331.TW) Income Statement Analysis – Financial Results
- Anjani Foods Limited (ANJANIFOODS.BO) Income Statement Analysis – Financial Results
- Boosh Plant-Based Brands Inc. (VGGIF) Income Statement Analysis – Financial Results
- CP ALL Public Company Limited (CPALL-R.BK) Income Statement Analysis – Financial Results
Clínica Baviera, S.A. (CBAV.MC)
About Clínica Baviera, S.A.
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 224.92M | 198.45M | 172.73M | 122.63M | 124.33M | 109.29M | 99.88M | 91.57M | 85.53M | 82.62M | 79.98M | 89.88M | 93.59M | 89.68M | 83.14M | 87.94M | 78.38M | 63.53M | 43.40M |
Cost of Revenue | 27.07M | 25.50M | 21.48M | 15.25M | 14.69M | 12.83M | 11.33M | 11.78M | 11.60M | 11.32M | 8.45M | 9.91M | 10.38M | 9.51M | 7.67M | 7.90M | 5.83M | 3.49M | 0.00 |
Gross Profit | 197.85M | 172.95M | 151.25M | 107.37M | 109.65M | 96.46M | 88.55M | 79.79M | 73.92M | 71.30M | 71.52M | 79.97M | 83.21M | 80.17M | 75.47M | 80.04M | 72.55M | 60.04M | 43.40M |
Gross Profit Ratio | 87.96% | 87.15% | 87.56% | 87.56% | 88.19% | 88.26% | 88.65% | 87.14% | 86.43% | 86.30% | 89.43% | 88.98% | 88.91% | 89.40% | 90.77% | 91.02% | 92.56% | 94.50% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 427.00K | 591.00K | 1.02M | 788.00K | 508.00K | 545.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 15.85M | 18.34M | 14.79M | 9.17M | 10.90M | 9.20M | 8.86M | 7.23M | 7.14M | 6.23M | 6.96M | 7.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.90M |
Selling & Marketing | 10.31M | 9.86M | 8.42M | 5.79M | 8.22M | 7.30M | 7.89M | 6.29M | 5.82M | 5.72M | 5.54M | 7.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 26.16M | 28.21M | 23.21M | 14.96M | 19.12M | 16.50M | 16.75M | 13.52M | 12.96M | 11.95M | 12.49M | 14.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.90M |
Other Expenses | 121.67M | 102.63M | 88.57M | 71.90M | 72.14M | 62.97M | 58.17M | 54.67M | 54.42M | 53.71M | 51.15M | 61.30M | 75.17M | 72.54M | 71.45M | 69.28M | 54.26M | 40.38M | -5.71M |
Operating Expenses | 147.84M | 130.83M | 111.78M | 86.86M | 91.25M | 79.48M | 74.92M | 68.19M | 67.39M | 65.67M | 63.65M | 76.27M | 75.17M | 72.54M | 71.45M | 69.28M | 54.26M | 40.38M | 10.19M |
Cost & Expenses | 174.88M | 156.33M | 133.27M | 102.12M | 105.94M | 92.31M | 86.26M | 79.97M | 78.99M | 76.99M | 72.10M | 86.17M | 85.55M | 82.05M | 79.12M | 77.18M | 60.08M | 43.87M | 10.19M |
Interest Income | 151.34K | 67.21K | 3.19K | 8.01K | 1.81K | 3.45K | 5.69K | 30.38K | 624.41K | 86.65K | 225.30K | 241.40K | 47.96K | 167.40K | 139.18K | 566.61K | 399.14K | 174.97K | 301.87K |
Interest Expense | 571.65K | 418.83K | 458.30K | 535.09K | 591.69K | 164.11K | 202.17K | 288.30K | 379.24K | 483.70K | 465.90K | 617.90K | 470.03K | 747.16K | 1.23M | 1.57M | 399.14K | 174.97K | 313.61K |
Depreciation & Amortization | 16.98M | 15.00M | 14.09M | 13.55M | 13.23M | 4.96M | 4.39M | 4.88M | 4.85M | 5.00M | 4.57M | 5.92M | 6.44M | 6.86M | 7.39M | 6.46M | 4.22M | 3.08M | 2.94M |
EBITDA | 67.22M | 56.15M | 53.49M | 34.06M | 31.53M | 21.93M | 18.02M | 16.51M | 11.88M | 10.69M | 11.82M | 8.81M | 14.53M | 14.66M | 11.55M | 17.78M | 22.77M | 22.74M | 17.62M |
EBITDA Ratio | 29.89% | 28.71% | 30.99% | 27.94% | 25.50% | 20.08% | 18.04% | 18.03% | 14.04% | 12.98% | 15.85% | 10.98% | 15.52% | 16.35% | 13.89% | 20.22% | 28.72% | 35.80% | -25.65% |
Operating Income | 50.01M | 41.49M | 39.43M | 20.51M | 18.32M | 16.98M | 13.63M | 11.61M | 6.51M | 5.63M | 7.04M | 602.60K | 8.09M | 7.80M | 4.16M | 11.32M | 18.30M | 19.66M | -14.07M |
Operating Income Ratio | 22.24% | 20.91% | 22.83% | 16.73% | 14.73% | 15.54% | 13.64% | 12.67% | 7.61% | 6.81% | 8.81% | 0.67% | 8.64% | 8.70% | 5.00% | 12.87% | 23.34% | 30.94% | -32.41% |
Total Other Income/Expenses | -360.98K | -812.54K | -529.83K | -323.08K | -528.57K | -173.04K | -198.62K | -263.14K | 139.02K | -420.37K | -263.72K | -227.81K | -422.07K | -579.76K | -1.10M | -1.00M | -36.20M | -39.14M | -47.59M |
Income Before Tax | 49.65M | 40.68M | 38.90M | 20.19M | 17.79M | 16.81M | 13.43M | 11.34M | 6.65M | 5.21M | 6.78M | 191.11K | 7.62M | 7.05M | 2.93M | 9.75M | -17.90M | -19.48M | -14.38M |
Income Before Tax Ratio | 22.08% | 20.50% | 22.52% | 16.46% | 14.31% | 15.38% | 13.44% | 12.39% | 7.78% | 6.30% | 8.48% | 0.21% | 8.14% | 7.86% | 3.52% | 11.09% | -22.83% | -30.67% | -33.14% |
Income Tax Expense | 12.92M | 10.53M | 10.97M | 6.05M | 4.89M | 4.90M | 3.55M | 3.40M | 1.81M | 1.21M | 2.08M | 831.74K | 2.22M | 1.81M | 1.06M | 2.99M | 5.86M | 6.82M | 5.00M |
Net Income | 35.97M | 29.52M | 27.39M | 13.94M | 12.79M | 11.83M | 9.77M | 7.91M | 4.88M | 4.05M | 4.89M | -87.59K | 5.40M | 5.24M | 1.86M | 7.01M | -23.67M | -26.29M | 9.38M |
Net Income Ratio | 15.99% | 14.87% | 15.86% | 11.37% | 10.29% | 10.82% | 9.78% | 8.64% | 5.71% | 4.91% | 6.11% | -0.10% | 5.77% | 5.84% | 2.24% | 7.97% | -30.19% | -41.38% | 21.61% |
EPS | 2.21 | 1.81 | 1.68 | 0.86 | 0.78 | 0.73 | 0.60 | 0.49 | 0.30 | 0.25 | 0.30 | -0.01 | 0.33 | 0.32 | 0.11 | 0.43 | -1.45 | -1.61 | 0.58 |
EPS Diluted | 2.21 | 1.81 | 1.68 | 0.86 | 0.78 | 0.73 | 0.60 | 0.49 | 0.30 | 0.25 | 0.30 | -0.01 | 0.33 | 0.32 | 0.11 | 0.43 | -1.45 | -1.61 | 0.58 |
Weighted Avg Shares Out | 16.30M | 16.30M | 16.30M | 16.30M | 16.30M | 16.30M | 16.31M | 16.31M | 16.30M | 16.30M | 16.29M | 16.31M | 16.21M | 16.22M | 16.31M | 16.31M | 16.31M | 16.29M | 16.22M |
Weighted Avg Shares Out (Dil) | 16.30M | 16.30M | 16.30M | 16.30M | 16.30M | 16.30M | 16.31M | 16.31M | 16.30M | 16.30M | 16.29M | 16.31M | 16.21M | 16.22M | 16.31M | 16.31M | 16.31M | 16.29M | 16.22M |
Source: https://incomestatements.info
Category: Stock Reports